AzTrials
AzTrials

Perinatal Mental HealthNCT06040359

Pilot Evaluation of the Thriving Mamas Programme

A study testing The Thriving Mamas programme in people with Perinatal Mental Health, run by King's College London at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot study is to evaluate the feasibility, appropriateness, and acceptability of a mental health prevention intervention among adolescents during pregnancy and the year after birth (perinatal period) in Kenya and Mozambique. Read more about this study

Who is it for?
Ages 15 years and olderHealthy volunteers can take part
Conditions the study is for
Perinatal Mental Health
What is being tested?
The Thriving Mamas programme
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
141 participants
Where
2 sitesin 2 countries
Study dates
1 Oct 2023to 15 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Mentor mothers: (A) aged 20 years or older; (B) female; (C) experience of pregnancy and/or parenting; and (D) live within the study site
  • Adolescent girls: (A) up to 28 weeks pregnant; and (B) aged 15-19 years
  • Friends/family members: (A) identified by an adolescent or young woman participating in the study; (B) participation agreed by other participating girls; and (C) aged 18 years or older

Who cannot join

  • Mentor mothers will be excluded from participating if they are unable to attend training or deliver the intervention sessions
  • Adolescent girls will be excluded from the study if they are unable to provide informed consent or are unable to participate in the intervention, due to existing health conditions
  • Friends/family members will not be excluded so long as they meet inclusion criteria

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Kenya1 site
  • Aga Khan University

    Nairobi

Other trials in Kenya

Mozambique1 site
  • Centro Internacional para Saude Reprodutiva Mocambique

    Maputo

Other trials in Mozambique

About this study

Official title: Pilot Evaluation of the Thriving Mamas Programme for Adolescent Perinatal Mental Health

The goal of this pilot study is to evaluate the feasibility, appropriateness, and acceptability of a mental health prevention intervention among adolescents during pregnancy and the year after birth (perinatal period) in Kenya and Mozambique. The main questions it aims to answer are:

  • Is the intervention feasible, acceptable, appropriate, and delivered/received with high fidelity, to adolescent girls, their friends/family members and service providers?
  • Are the implementation strategies acceptable, appropriate, feasible to all relevant stakeholders?
  • What impact does the intervention have on adolescent mothers' mental health?
  • What impact does the intervention have on adolescent mothers' social, economic, and education outcomes?
Read more

Participants will:

  • Participate in nine individual and group sessions focused on improving mental and perinatal health literacy and increasing life skills
  • Receive standard perinatal care

Researchers will compare findings with girls receiving standard perinatal care only to see if the intervention has an impact on adolescents' mental health, social, economic and education outcomes.

Being tested
The Thriving Mamas programme, Usual care
Keywords
Adolescent mental health, Maternal mental health

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Thriving Mamas programmeOther

    Enhanced antenatal course plus usual perinatal care

  • Usual careOther

    Usual perinatal care

Study groups in NCT06040359
Study groupRoleWhat they receive
Thriving Mama programmeExperimentalNine meetings delivered in either group (5 meetings), individual (1 meeting), or family group (2 meetings) formats over 10 weeks with an additional individual meeting 10-12 weeks postpartum by a trained mother in the community. Each meeting focuses on the girl's physical and mental health, taking care of a newborn, life skills, future-planning and social support and community-based services. Meetings will take place in a mixture of private settings in health facilities, community facilities, and participant homes. Adolescents will also receive usual perinatal care.
Receives: Other: The Thriving Mamas programme
Usual perinatal careActive comparatorEach visit includes care that is appropriate to the overall condition and stage of pregnancy and should include four main categories of care: 1. Identification of pre-existing health conditions (e.g., check for weight and nutrition status, anemia, hypertension, syphilis, HIV status); 2. Early detection of complications arising during pregnancy (e.g., check for pre-eclampsia, gestational diabetes); 3. Health promotion and disease prevention (e.g., tetanus vaccine, prevention and treatment of malaria, nutrition counseling, micronutrient supplements, family planning counseling); and 4. Birth preparedness and complication planning (e.g., birth and emergency plan, breastfeeding counseling, antiretrovirals for HIV positive women and reducing mother-to- child transmission of HIV)
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention Feasibility

    Feasibility of Intervention Measure (FIM); Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Minimum=5, Maximum=25; higher score is better

    Measured: 10-12 weeks post-partum

  2. Intervention Acceptability

    Acceptability of Intervention Measure (AIM); Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Minimum=5, Maximum=25; higher score is better

    Measured: 10-12 weeks post-partum

  3. Intervention Appropriateness

    Intervention Appropriateness Measure (IAM); Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Minimum=5, Maximum=25; higher score is better

    Measured: 10-12 weeks post-partum

  4. Intervention Fidelity

    Enhancing Assessment of Common Therapeutic Factors (ENACT); subjective report of provider fidelity and perception of care; Minimum=0; Maximum=13; higher score is better

    Measured: Through intervention delivery, an average of 24 weeks

Secondary outcomes (21)
  1. Training Feasibility

    Feasibility of Intervention Measure (FIM); Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Minimum=5, Maximum=25; higher score is better

    Measured: Immediately after provider training

  2. Training Acceptability

    Acceptability of Intervention Measure (AIM); Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Minimum=5, Maximum=25; higher score is better

    Measured: Immediately after provider training

  3. Training Appropriateness

    Intervention Appropriateness Measure (IAM); Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Minimum=5, Maximum=25; higher score is better

    Measured: Immediately after provider training

  4. Knowledge

    Study-specific measure of mentor mothers' knowledge of issues regarding pregnancy, childbirth, caregiving, mental health, and referral pathways will be assessed using a study-specific quiz based upon the intervention manual; Minimum=0, Maximum=16; higher score is better

    Measured: Baseline and immediately after provider training

  5. Change in mental health attitudes

    Social Distance Scale (SDS); The SDS measures the acceptability of different degrees of social distance and, by inference, the attitude of the respondent to the person with the condition; Minimum=1, Maximum=96; higher score is better

    Measured: Baseline and immediately after provider training

  6. Change in adolescent pregnancy attitudes

    Study-specific attitudes towards adolescent pregnancy survey; Minimum=4, Maximum=20; lower score is better

    Measured: Baseline and immediately after provider training

  7. Provider competency

    Study-specific single 10-point scale to assess provider ability to deliver the intervention; Minimum=0, Maximum=10; higher score is better

    Measured: Immediately after provider training

  8. Recruitment rate

    Proportion of adolescents providing consent to participate in the study

    Measured: pre-intervention

  9. Cost of intervention

    Total and average cost of the intervention per participant

    Measured: through study completion, an average of 24 weeks

  10. Change in adolescent depression

    Patient Health Questionnaire (PHQ-9); Nine-item screening tool which assesses depression symptoms according to clinical criteria. Minimum=0, Maximum=27. A score ≥10 indicates moderate to severe depression.

    Measured: through study completion, an average of 24 weeks

  11. Change in adolescent anxiety

    Generalised Anxiety Disorder scale (GAD-7); Seven-item screening tool which assesses anxiety symptoms according to clinical criteria. Minimum=0, Maximum=21. A score ≥10 indicates moderate to severe anxiety.

    Measured: through study completion, an average of 24 weeks

  12. Change in adolescent quality of life

    WHO Quality of Life brief version (WHOQOL-BREF); 26-item scale assesses a respondent's perceived quality of life across four domains: physical health; psychological; social relationships; and environment. Total minimum=25, Total maximum=125. Higher scores indicate greater quality of life in a particular domain.

    Measured: through study completion, an average of 24 weeks

  13. Change in adolescent social support

    Multidimensional Scale of Perceived Social Support (MSPSS); The MSPSS is a 12-item scale which measures social support from family, friends and significant others. Minimum=12, Maximum=84. Higher scores indicate greater social support.

    Measured: through study completion, an average of 24 weeks

  14. Adolescent parenting competency

    Parenting Sense of Competency Scale; 17-item scale to measure adolescents' perceived parenting abilities. Minimum=17, Maximum=102. Higher scores indicate greater perceived competence.

    Measured: through study completion, an average of 24 weeks

  15. Perinatal appointment attendance

    Number of participants attending antenatal appointments

    Measured: through study completion, an average of 24 weeks

  16. Referral uptake

    Proportion of adolescents attending referral appointments

    Measured: 10-12 weeks post-partum

  17. Change in infant vaccination

    Number of participants intending to or having had their babies vaccinated

    Measured: Baseline and 10-12 weeks post-partum

  18. Change in breastfeeding

    Number of participants intendng to or are currently breastfeeding

    Measured: Baseline and 10-12 weeks post-partum

  19. Change in intended time to next pregnancy

    Study-specific health behaviours questionnaire to assess intended or actual contraceptive Nuimber of participants that want more children who intend to wait at least 15 months before next pregnancy

    Measured: Baseline and 10-12 weeks post-partum

  20. Change in contraceptive use

    Number of participants intending to or currently using contraceptives to delay pregnancy

    Measured: Baseline and 10-12 weeks post-partum

  21. Change in perception of intervention

    Study-specific five-item measure assessing knowledge gained, interest in intervention, and support recieved; Minimum=0; Maximum=5; higher score is better

    Measured: Baseline and 10-12 weeks post-partum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2023
  2. Study start1 Oct 2023
  3. Primary completion15 Sep 2024
  4. Study completion15 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
141 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06040359
Sponsor's protocol ID
HR/DP-22/23-39521
Status last verified
Jan 2025
First submitted
23 Aug 2023
Last updated
16 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Taylor Salisbury T, Maguele MSB, Chissale F, de Melo M, Hanselmann M, Lamahewa K, Lang'at E, Mandlate F, Nyaga L, Seward N, Temmerman M. Supporting the mental health of adolescent mothers in Kenya and Mozambique: pilot protocol for the Thriving Mamas programme. Pilot Feasibility Stud. 2025 Jun 19;11(1):83. doi: 10.1186/s40814-025-01617-5.

    PubMed 40537871

Questions about this trial

What is this clinical trial studying?

A study testing The Thriving Mamas programme in people with Perinatal Mental Health, run by King's College London at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Kenya, Mozambique. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention Feasibility (time frame: 10-12 weeks post-partum). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06040359, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in